Current Neurology and Neuroscience Reports

, Volume 10, Issue 2, pp 133–139 | Cite as

The Association of Migraine with Ischemic Stroke

  • Tobias KurthEmail author


Migraine is a common, chronic–intermittent primary headache disorder affecting mostly women. The migraine pathophysiology involves both the neuronal and vascular systems, and in some patients, transient neurologic symptoms occur, which are known as migraine aura. A large body of literature supports an association between migraine and ischemic stroke, which is apparent mostly in young women with migraine with aura. Further increased risks have been observed particularly in smokers and women who use oral contraceptives. The vast majority of individual studies, as well as a recent meta-analysis, did not find an association between migraine without aura and ischemic stroke. Although there are several hypotheses about potential biological mechanisms linking migraine with aura to ischemic stroke, the precise causes remain unclear. Because the absolute risk of stroke is considerably low in patients with migraine, the vast majority of migraine patients will not experience a stroke event because of the migraine.


Migraine Stroke Epidemiology 



Dr. Kurth has received investigator-initiated research funding from the French National Research Agency, the National Institutes of Health, Merck, and the Migraine Research Foundation. He is a consultant to I3 Drug Safety and World Health Information Science Consultants, LLC, and has received honoraria from Genzyme, Merck, and Pfizer for educational lectures as well as travel funds from the Restless Legs Syndrome Foundation.


Papers of particular interest to this topic, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Silberstein SD: Migraine. Lancet 2004, 363:381–391.CrossRefPubMedGoogle Scholar
  2. 2.
    Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(Suppl 1):3S–10S.PubMedGoogle Scholar
  3. 3.
    Tietjen GE: Migraine as a systemic disorder. Neurology 2007, 68:1555–1556.CrossRefPubMedGoogle Scholar
  4. 4.
    Henrich JB, Horwitz RI: A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989, 42:773–780.CrossRefPubMedGoogle Scholar
  5. 5.
    Tzourio C, Iglesias S, Hubert JB, et al.: Migraine and risk of ischaemic stroke: a case-control study. BMJ 1993, 307:289–292.CrossRefPubMedGoogle Scholar
  6. 6.
    Tzourio C, Tehindrazanarivelo A, Iglesias S, et al.: Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995, 310:830–833.PubMedGoogle Scholar
  7. 7.
    Chang CL, Donaghy M, Poulter N: Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999, 318:13–18.Google Scholar
  8. 8.
    Stang PE, Carson AP, Rose KM, et al.: Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005, 64:1573–1577.CrossRefPubMedGoogle Scholar
  9. 9.
    Lidegaard O: Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Brit J Obstet Gynaecol 1995, 102:153–159.Google Scholar
  10. 10.
    Carolei A, Marini C, De Matteis G: History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996, 347:1503–1506.Google Scholar
  11. 11.
    Hall GC, Brown MM, Mo J, MacRae KD: Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563–568.PubMedGoogle Scholar
  12. 12.
    MacClellan LR, Giles WH, Cole J, et al.: Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke 2007, 38:2438–2445.CrossRefPubMedGoogle Scholar
  13. 13.
    Kurth T, Gaziano JM, Berger K, et al.: Body mass index and the risk of stroke in men. Arch Intern Med 2002, 162:2557–2562.CrossRefPubMedGoogle Scholar
  14. 14.
    Kurth T, Gaziano JM, Cook NR, et al.: Migraine and risk of cardiovascular disease in women. JAMA 2006, 296:283–291.CrossRefPubMedGoogle Scholar
  15. 15.
    Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747–750.CrossRefPubMedGoogle Scholar
  16. 16.
    Haapaniemi H, Hillbom M, Juvela S: Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 1997, 28:26–30.PubMedGoogle Scholar
  17. 17.
    Kurth T, Gaziano JM, Cook N, et al.: Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007, 167:795–801.CrossRefPubMedGoogle Scholar
  18. 18.
    Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330:63–65.CrossRefPubMedGoogle Scholar
  19. 19.
    •• Schürks M, Rist PM, Bigal ME, et al.: Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339:b3914. This is the most recent meta-analysis linking migraine to risk of ischemic stroke and other ischemic vascular events.Google Scholar
  20. 20.
    Bushnell CD, Jamison M, James AH: Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 2009, 338:b664.CrossRefPubMedGoogle Scholar
  21. 21.
    Osborn RE, Alder DC, Mitchell CS: MR imaging of the brain in patients with migraine headaches. Am J Neuroradiol 1991, 12:521–524.PubMedGoogle Scholar
  22. 22.
    Igarashi H, Sakai F, Kan S, et al.: Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991, 11:69–74.CrossRefPubMedGoogle Scholar
  23. 23.
    Pavese N, Canapicchi R, Nuti A, et al.: White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia 1994, 14:342–345.CrossRefPubMedGoogle Scholar
  24. 24.
    De Benedittis G, Lorenzetti A, Sina C, Bernasconi V: Magnetic resonance imaging in migraine and tension-type headache. Headache 1995, 35:264–268.CrossRefPubMedGoogle Scholar
  25. 25.
    Swartz RH, Kern RZ: Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004, 61:1366–1368.CrossRefPubMedGoogle Scholar
  26. 26.
    Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427–434.CrossRefPubMedGoogle Scholar
  27. 27.
    •• Scher AI, Gudmundsson LS, Sigurdsson S, et al.: Migraine headache in middle age and late-life brain infarcts. JAMA 2009, 301:2563–2570. This population-based study linked migraine to late-life infarct-like lesions.Google Scholar
  28. 28.
    Olesen J, Friberg L, Olsen TS, et al.: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990, 28:791–798.CrossRefPubMedGoogle Scholar
  29. 29.
    Kurth T, Schürks M, Logroscino G, Buring JE: Migraine frequency and risk of cardiovascular disease in women. Neurology 2009, 73:581–588.CrossRefPubMedGoogle Scholar
  30. 30.
    Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988, 8:1–96.Google Scholar
  31. 31.
    Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.Google Scholar
  32. 32.
    Tzourio C, Benslamia L, Guillon B, et al.: Migraine and the risk of cervical artery dissection: a case-control study. Neurology 2002, 59:435–437.PubMedGoogle Scholar
  33. 33.
    Pezzini A, Granella F, Grassi M, et al.: History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia 2005, 25:575–580.CrossRefPubMedGoogle Scholar
  34. 34.
    Bousser MG, Welch KM: Relation between migraine and stroke. Lancet Neurol 2005, 4:533–542.CrossRefPubMedGoogle Scholar
  35. 35.
    Waeber C, Moskowitz MA: Migraine as an inflammatory disorder. Neurology 2005, 64:S9–S15.PubMedGoogle Scholar
  36. 36.
    Scher AI, Terwindt GM, Picavet HS, et al.: Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005, 64:614–620.PubMedGoogle Scholar
  37. 37.
    Kurth T, Schürks M, Logroscino G, et al.: Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008, 337:a636.CrossRefPubMedGoogle Scholar
  38. 38.
    Diener HC, Kurth T, Dodick D: Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007, 20:310–319.CrossRefPubMedGoogle Scholar
  39. 39.
    Nozari A, Dilekoz E, Sukhotinsky I, et al.: Microemboli may link spreading depression migraine aura and patent foramen ovale. Ann Neurol 2009, doi: 10.1002/ana.21871.
  40. 40.
    Schwedt TJ, Demaerschalk BM, Dodick DW: Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008, 28:531–540.CrossRefPubMedGoogle Scholar
  41. 41.
    Rundek T, Elkind MS, Di Tullio MR, et al.: Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008, 118:1419–1424.CrossRefPubMedGoogle Scholar
  42. 42.
    Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648–1651.CrossRefPubMedGoogle Scholar
  43. 43.
    Dowson A, Mullen MJ, Peatfield R, et al.: Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008, 117:1397–1404.CrossRefPubMedGoogle Scholar
  44. 44.
    Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543–552.CrossRefPubMedGoogle Scholar
  45. 45.
    Mulder EJ, Van Baal C, Gaist D, et al.: Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003, 6:422–431.CrossRefPubMedGoogle Scholar
  46. 46.
    Moskowitz MA: Pathophysiology of headache—past and present. Headache 2007, 47(Suppl 1):S58–S63.CrossRefPubMedGoogle Scholar
  47. 47.
    Dodick DW, Martin VT, Smith T, Silberstein S: Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 2004, 44:S20–S30.CrossRefPubMedGoogle Scholar
  48. 48.
    Velentgas P, Cole JA, Mo J, et al.: Severe vascular events in migraine patients. Headache 2004, 44:642–651.CrossRefPubMedGoogle Scholar
  49. 49.
    Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, et al.: Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006, 67:1128–1134.Google Scholar
  50. 50.
    Loder E: Migraine with aura and increased risk of ischaemic stroke. BMJ 2009, 339:b4380.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.INSERM Unit 708 – NeuroepidemiologyHôpital de la Pitié-SalpêtrièreParisFrance

Personalised recommendations